The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Protein drug stability: a formulation challenge
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive supramolecular chemistry
(1997) · Choice Reviews Online · doi:10.5860/choice.34-5097 · Cited by 6,476
Protein folding and misfolding
Dobson, C. M. (2003) · Nature · doi:10.1038/nature02261 · Cited by 4,791
Hydrogels in pharmaceutical formulations
Peppas, N. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00090-4 · Cited by 4,011
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Common core structure of amyloid fibrils by synchrotron X-ray diffraction 1 1Edited by F. E. Cohen
Sunde, M., Serpell, L. C., Bartlam, M., Fraser, P. E., Pepys, M. B., & Blake, C. C. F. (1997) · Journal of Molecular Biology · doi:10.1006/jmbi.1997.1348 · Cited by 1,707
Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils
Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687
Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins
Fernandez-Escamilla, A.-M., Rousseau, F., Schymkowitz, J., & Serrano, L. (2004) · Nature Biotechnology · doi:10.1038/nbt1012 · Cited by 1,658
Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652
Chi, E. Y., Krishnan, S., Randolph, T. W., & Carpenter, J. F. (2003) · Pharmaceutical Research · doi:10.1023/a:1025771421906 · Cited by 1,379
A trip to the ER: coping with stress
Rutkowski, D. T., & Kaufman, R. J. (2004) · Trends in Cell Biology · doi:10.1016/j.tcb.2003.11.001 · Cited by 1,355
Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation
Chapman, M. R., Robinson, L. S., Pinkner, J. S., Roth, R., Heuser, J., Hammar, M., Normark, S., & Hultgren, S. J. (2002) · Science · doi:10.1126/science.1067484 · Cited by 1,298
Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J.-J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa011931 · Cited by 1,246
Nanostructured lipid matrices for improved microencapsulation of drugs
Müller, R. H., Radtke, M., & Wissing, S. A. (2002) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00180-1 · Cited by 1,226
Lyophilization and development of solid protein pharmaceuticals
Wang, W. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00423-3 · Cited by 1,175
Protein aggregation: folding aggregates, inclusion bodies and amyloid
Fink, A. L. (1998) · Folding and Design · doi:10.1016/s1359-0278(98)00002-9 · Cited by 1,157
Macromolecular crowding: an important but neglected aspect of the intracellular environment
Ellis, R. J. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00172-x · Cited by 1,153
Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein Adduct
Conway, K. A., Rochet, J.-C., Bieganski, R. M., & Lansbury, P. T. (2001) · Science · doi:10.1126/science.1063522 · Cited by 1,127
How Hofmeister ion interactions affect protein stability
Baldwin, R. L. (1996) · Biophysical Journal · doi:10.1016/s0006-3495(96)79404-3 · Cited by 1,124
Rationalization of the effects of mutations on peptide andprotein aggregation rates
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., & Dobson, C. M. (2003) · Nature · doi:10.1038/nature01891 · Cited by 1,072
Instability, stabilization, and formulation of liquid protein pharmaceuticals
Wang, W. (1999) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(99)00152-0 · Cited by 1,064
Dobson, C. M. (2004) · Nature · doi:10.1038/nature03192 · Cited by 1,003
Protein aggregation and its inhibition in biopharmaceutics
Wang, W. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.11.014 · Cited by 983
Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand
Tjernberg, L. O., Näslund, J., Lindqvist, F., Johansson, J., Karlström, A. R., Thyberg, J., Terenius, L., & Nordstedt, C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.15.8545 · Cited by 963
Challenges in the development of high protein concentration formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20079 · Cited by 882
Why are enzymes less active in organic solvents than in water?
Klibanov, A. M. (1997) · Trends in Biotechnology · doi:10.1016/s0167-7799(97)01013-5 · Cited by 729
Knudsen, L. B., Nielsen, P. F., Huusfeldt, P. O., Johansen, N. L., Madsen, K., Pedersen, F. Z., Thøgersen, H., Wilken, M., & Agersø, H. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm9909645 · Cited by 700
Frömming, K.-H., & Szejtli, J. (1994) · Topics in Inclusion Science · doi:10.1007/978-94-015-8277-3 · Cited by 658
Challenges in the Development of High Protein Concentration Formulations
Shire, S. J., Shahrokh, Z., & Liu, J. (2010) · Current Trends in Monoclonal Antibody Development and Manufacturing · doi:10.1007/978-0-387-76643-0_9 · Cited by 657
Structure-Immunogenicity Relationships of Therapeutic Proteins
Hermeling, S., Crommelin, D. J. A., Schellekens, H., & Jiskoot, W. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000029275.41323.a6 · Cited by 617
Cleland, J. L., Powell, M., & Shire, S. J. (1993) · PubMed · Cited by 543
Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins
Taniguchi, S., Suzuki, N., Masuda, M., Hisanaga, S.-I., Iwatsubo, T., Goedert, M., & Hasegawa, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m408714200 · Cited by 540
[17] Analysis of protein aggregation kinetics
Ferrone, F. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09019-9 · Cited by 539
Huntington's disease age-of-onset linked to polyglutamine aggregation nucleation
Chen, S., Ferrone, F. A., & Wetzel, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182276099 · Cited by 523
Toward Understanding Insulin Fibrillation
Brange, J., Andersen, L., Laursen, E. D., Meyn, G., & Rasmussen, E. (1997) · Journal of Pharmaceutical Sciences · doi:10.1021/js960297s · Cited by 510
Protein Hydration, Thermodynamic Binding, and Preferential Hydration
Timasheff, S. N. (2002) · Biochemistry · doi:10.1021/bi020316e · Cited by 509
Amyloid fibers are water-filled nanotubes
Perutz, M. F., Finch, J. T., Berriman, J., & Lesk, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.042681399 · Cited by 506
Eisenberg, N., Fabes, R. A., & Guthrie, I. K. (1997) · Issues in clinical child psychology · doi:10.1007/978-1-4757-2677-0_2 · Cited by 475
A Simple Method for Improving Protein Solubility and Long-Term Stability
Golovanov, A. P., Hautbergue, G. M., Wilson, S. A., & Lian, L.-Y. (2004) · Journal of the American Chemical Society · doi:10.1021/ja049297h · Cited by 466
Freeze-drying of bioproducts: putting principles into practice
Franks, F. (1998) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(98)00004-6 · Cited by 461
Seeding Specificity in Amyloid Growth Induced by Heterologous Fibrils
O'Nuallain, B., Williams, A. D., Westermark, P., & Wetzel, R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311300200 · Cited by 423
Kinetic partitioning of protein folding and aggregation
Chiti, F., Taddei, N., Baroni, F., Capanni, C., Stefani, M., Ramponi, G., & Dobson, C. M. (2002) · Nature Structural Biology · doi:10.1038/nsb752 · Cited by 422
In situ forming parenteral drug delivery systems: an overview
Packhaeuser, C. B., Schnieders, J., Oster, C. G., & Kissel, T. (2004) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.03.003 · Cited by 413
Sorensen, P. S., Ross, C., Clemmesen, K. M., Bendtzen, K., Frederiksen, J. L., Jensen, K., Kristensen, O., Petersen, T., Rasmussen, S., Ravnborg, M., et al. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14541-2 · Cited by 383
Monomeric Insulins and Their Experimental and Clinical Implications
Brange, J., Owens, D. R., Kang, S., & Vølund, A. (1990) · Diabetes Care · doi:10.2337/diacare.13.9.923 · Cited by 369
Phospholipid Catalysis of Diabetic Amyloid Assembly
Knight, J. D., & Miranker, A. D. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.086 · Cited by 357
Kurtzhals, P., Havelund, S., Jonassen, I., Kiehr, B., Larsen, U. D., Ribel, U., & Markussen, J. (1995) · Biochemical Journal · doi:10.1042/bj3120725 · Cited by 334
Recombinant protein therapeutics—success rates, market trends and values to 2010
Pavlou, A. K., & Reichert, J. M. (2004) · Nature Biotechnology · doi:10.1038/nbt1204-1513 · Cited by 334
Probing the Mechanism of Insulin Fibril Formation with Insulin Mutants
Nielsen, L., Frokjaer, S., Brange, J., Uversky, V. N., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi0105983 · Cited by 328
Self-citationPrediction of the Absolute Aggregation Rates of Amyloidogenic Polypeptide Chains
DuBay, K. F., Pawar, A. P., Chiti, F., Zurdo, J., Dobson, C. M., & Vendruscolo, M. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.043 · Cited by 318
Water as a plasticizer: physico-chemical aspects of low-moisture polymeric systems
Levine, H., & Slade, L. (1988) · Water Science Reviews 3 · doi:10.1017/cbo9780511552083.002 · Cited by 293
Smart and genetically engineered biomaterials and drug delivery systems
Kopeček, J. (2003) · European Journal of Pharmaceutical Sciences · doi:10.1016/s0928-0987(03)00164-7 · Cited by 292
Biodegradable mucoadhesive particulates for nasal and pulmonary antigen and DNA delivery
ALPAR, H., SOMAVARAPU, S., ATUAH, K., & BRAMWELL, V (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.09.004 · Cited by 287
Formation of Amyloid Fibers Triggered by Phosphatidylserine-Containing Membranes
Zhao, H., Tuominen, E. K. J., & Kinnunen, P. K. J. (2004) · Biochemistry · doi:10.1021/bi049002c · Cited by 273
Polyethylene glycol–superoxide dismutase, a conjugate in search of exploitation
Veronese, F. M., Caliceti, P., Schiavon, O., & Sergi, M. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00029-7 · Cited by 273
[15] Inhibition of aggregation side reactions during in vitro protein folding
De Bernardez Clark, E., Schwarz, E., & Rudolph, R. (1999) · Methods in Enzymology · doi:10.1016/s0076-6879(99)09017-5 · Cited by 255
Ross, C., Clemmesen, K. M., Svenson, M., S�rensen, P. S., Koch‐Henriksen, N., Skovgaard, G. L., Bendtzen, K., & the Danish Multiple Sclerosis Study Group (2000) · Annals of Neurology · doi:10.1002/1531-8249(200011)48:5<706::aid-ana3>3.0.co;2-v · Cited by 240
Introduction and overview of peptide and protein pegylation
(2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00020-0 · Cited by 235
Soluble, fatty acid acylated insulins bind to albumin and show protracted action in pigs
Markussen, J., Havelund, S., Kurtzhals, P., Andersen, A. S., Halstr�m, J., Hasselager, E., Larsen, U. D., Ribel, U., Sch�ffer, L., Vad, K., et al. (1996) · Diabetologia · doi:10.1007/bf00418343 · Cited by 233
Oxidative renaturation of lysozyme at high concentrations
Hevehan, D. L., & De Bernardez Clark, E. (1997) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19970505)54:3<221::aid-bit3>3.0.co;2-h · Cited by 231
Observation of sequence specificity in the seeding of protein amyloid fibrils
Krebs, M. R. H., Morozova‐Roche, L. A., Daniel, K., Robinson, C. V., & Dobson, C. M. (2004) · Protein Science · doi:10.1110/ps.04707004 · Cited by 228
Peptide Aggregation in Neurodegenerative Disease
Murphy, R. M. (2002) · Annual Review of Biomedical Engineering · doi:10.1146/annurev.bioeng.4.092801.094202 · Cited by 228
Wurth, C., Guimard, N. K., & Hecht, M. H. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00399-6 · Cited by 227
Manning, M., & Colón, W. (2004) · Biochemistry · doi:10.1021/bi0491898 · Cited by 225
Influence of excluded volume upon macromolecular structure and associations in ‘crowded” media
Minton, A. P. (1997) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(97)80159-0 · Cited by 212
Rapid Anionic Micelle-mediated α-Synuclein Fibrillization in Vitro
Necula, M., Chirita, C. N., & Kuret, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308231200 · Cited by 211
Inverse Relationship of Protein Concentration and Aggregation
Treuheit, M. J., Kosky, A. A., & Brems, D. N. (2002) · Pharmaceutical Research · doi:10.1023/a:1015108115452 · Cited by 209
Harnessing Chaperones to Generate Small-Molecule Inhibitors of Amyloid ß Aggregation
Gestwicki, J. E., Crabtree, G. R., & Graef, I. A. (2004) · Science · doi:10.1126/science.1101262 · Cited by 200
Artificial Chaperone-assisted Refolding of Carbonic Anhydrase B
Rozema, D., & Gellman, S. H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.7.3478 · Cited by 199
LONDON, J., SKRZYNIA, C., & GOLDBERG, M. E. (1974) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1974.tb03707.x · Cited by 197
Dityrosine as a product of oxidative stress and fluorescent probe
Malencik, D. A., & Anderson, S. R. (2003) · Amino Acids · doi:10.1007/s00726-003-0014-z · Cited by 186
Pegnology: a review of PEG-ylated systems.
Bhadra, D., Bhadra, S., Jain, P., & Jain, N. K. (2002) · PubMed · Cited by 183
A transient expansion of the native state precedes aggregation of recombinant human interferon-γ
Kendrick, B. S., Carpenter, J. F., Cleland, J. L., & Randolph, T. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14142 · Cited by 182
Protein folding in the cell: reshaping the folding funnel
CLARK, P. (2004) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2004.08.008 · Cited by 181
Otzen, D. E., Kristensen, O., & Oliveberg, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.160086297 · Cited by 177
Self-citationFraser, P. E., McLachlan, D. R. C., Surewicz, W. K., Mizzen, C. A., Snow, A. D., Nguyen, J. T., & Kirschner, D. A. (1994) · Journal of Molecular Biology · doi:10.1006/jmbi.1994.1704 · Cited by 156
Salt-induced detour through compact regions of the protein folding landscape
Otzen, D. E., & Oliveberg, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.21.11746 · Cited by 139
Self-citationStressed-out B cells? Plasma-cell differentiation and the unfolded protein response
Gass, J. K., Gunn, K., Sriburi, R., & Brewer, J. W. (2003) · Trends in Immunology · doi:10.1016/j.it.2003.11.004 · Cited by 134
Kardos, J., Yamamoto, K., Hasegawa, K., Naiki, H., & Goto, Y. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409677200 · Cited by 134
Machius, M., Declerck, N., Huber, R., & Wiegand, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212618200 · Cited by 126
Micelle-Associated Protein in Epoetin Formulations: A Risk Factor for Immunogenicity?
Hermeling, S., Schellekens, H., Crommelin, D. J. A., & Jiskoot, W. (2003) · Pharmaceutical Research · doi:10.1023/b:pham.0000008034.61317.02 · Cited by 124
Antibodies against rHuEPO: native and recombinant
Casadevall, N. (2002) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/17.suppl_5.42 · Cited by 122
Modulation of S6 Fibrillation by Unfolding Rates and Gatekeeper Residues
Pedersen, J. S., Christensen, G., & Otzen, D. E. (2004) · Journal of Molecular Biology · doi:10.1016/j.jmb.2004.06.020 · Cited by 118
Self-citationBiophysical mechanisms of phospholipase A2 activation and their use in liposome‐based drug delivery
Jørgensen, K., Davidsen, J. R., & Mouritsen, O. G. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)03408-7 · Cited by 117
Long–Term Stabilization of Biologicals
Franks, F. (1994) · Nature Biotechnology · doi:10.1038/nbt0394-253 · Cited by 114
Dailey, L. A., Wittmar, M., & Kissel, T. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.09.003 · Cited by 108
The Stability Factor: Importance in Formulation Development
Krishnamurthy, R., & Manning, M. C. (2002) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201023378229 · Cited by 103
Mishandling of the Therapeutic Peptide Glucagon Generates Cytotoxic Amyloidogenic Fibrils
Onoue, S., Ohshima, K., Debari, K., Koh, K., Shioda, S., Iwasa, S., Kashimoto, K., & Yajima, T. (2004) · Pharmaceutical Research · doi:10.1023/b:pham.0000033016.36825.2c · Cited by 99
Structural basis for cyclodextrins' suppression of human growth hormone aggregation
Otzen, D. E., Knudsen, B. R., Aachmann, F. L., Larsen, K. L., & Wimmer, R. (2002) · Protein Science · doi:10.1110/ps.0202702 · Cited by 93
Self-citationSilent Prions Lying in Wait: A Two-hit Model of Prion/Amyloid Formation and Infection
Hall, D. R., & Edskes, H. K. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.12.004 · Cited by 81
Formation of intermolecular .beta.-sheet structure during heat denaturation of ovalbumin
Kato, A., & Takagi, T. (1988) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf00084a007 · Cited by 76
Holm, J., Gajhede, M., Ferreras, M., Henriksen, A., Ipsen, H., Larsen, J. N., Lund, L., Jacobi, H. H., Millner, A. H., Würtzen, P. A., et al. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.8.5258 · Cited by 74
Peginterferon alfa-2a: A review of approved and investigational uses
Matthews, S. J., & McCoy, C. P. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90173-7 · Cited by 73
Pathological and functional amyloid formation orchestrated by the secretory pathway
Huff, M. E., Balch, W. E., & Kelly, J. W. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.010 · Cited by 68
Webb, S. D., Cleland, J. L., Carpenter, J. F., & Randolph, T. W. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10033 · Cited by 67
Evidence for an Intermediate in Tau Filament Formation
Chirita, C. N., & Kuret, J. (2004) · Biochemistry · doi:10.1021/bi036034b · Cited by 66
Sharma, L., & Sharma, A. K. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02125.x · Cited by 64
Putting principles into practice
Jamieson, J., Chapelle, C. A., & Preiss, S. (2004) · ReCALL · doi:10.1017/s0958344004001028 · Cited by 63
Lee, H., & Park, T. G. (2002) · Pharmaceutical Research · doi:10.1023/a:1016113117851 · Cited by 57
Role for the α-Helix in Aberrant Protein Aggregation
Kunjithapatham, R., Oliva, F. Y., Doshi, U., Pérez, M., Ávila, J., & Muñoz, V. (2004) · Biochemistry · doi:10.1021/bi048564t · Cited by 57
Palmitoyl Derivatives of Interferon α: Potential for Cutaneous Delivery
Földvári, M., ATTAH‐POKU, S. K., Hu, J., Li, Q., Hughes, H. P. A., Babiuk, A. L., & Kruger, S. (1998) · Journal of Pharmaceutical Sciences · doi:10.1021/js980146k · Cited by 56
Rzepecki, P., Nagel‐Steger, L., Feuerstein, S., Linne, U., Molt, O., Zadmard, R., Aschermann, K., Wehner, M., Schrader, T. H., & Riesner, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405914200 · Cited by 54
Probing Structural Changes of Proteins Incorporated into Water-in-Oil Emulsions
Jørgensen, L., van de Weert, M., Vermehren, C., Bjerregaard, S., & Frøkjær, S. (2004) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20097 · Cited by 49
A 50th Order Reaction Predicted and Observed for Sickle Hemoglobin Nucleation
Cao, Z., & Ferrone, F. A. (1996) · Journal of Molecular Biology · doi:10.1006/jmbi.1996.0079 · Cited by 47
Wang, J., Shen, D., & Shen, W. (1999) · Pharmaceutical Research · doi:10.1023/a:1018929312715 · Cited by 45
Designing drugs to stop the formation of prion aggregates and other amyloids
Masel, J., & Jansen, V. A. A. (2000) · Biophysical Chemistry · doi:10.1016/s0301-4622(00)00197-6 · Cited by 45
A simple way to measure protein refolding rates in water
Otzen, D. E., & Oliveberg, M. (2001) · Journal of Molecular Biology · doi:10.1006/jmbi.2001.5039 · Cited by 40
Self-citationRapid Assembly of Amyloid-β Peptide at a Liquid/Liquid Interface Produces Unstable β-Sheet Fibers
Nichols, M. R., Moss, M. A., Reed, D. K., Hoh, J. H., & Rosenberry, T. L. (2004) · Biochemistry · doi:10.1021/bi048846t · Cited by 40
Bjerregaard, S., Pedersen, H., Vedstesen, H., Vermehren, C., Söderberg, I., & Frøkjær, S. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00656-6 · Cited by 36
Simulations of kinetically irreversible protein aggregate structure
Patro, S. Y., & Przybycien, T. M. (1994) · Biophysical Journal · doi:10.1016/s0006-3495(94)80922-1 · Cited by 31
Pedersen, T. B., Sabra, M. C., Frøkjær, S., Mouritsen, O. G., & Jørgensen, K. (2001) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(01)00177-3 · Cited by 26
Correlation effects and electron delocalization in nonalternant hydrocarbon .pi. compounds
Boehm, M. C., & Schuett, J. (1992) · The Journal of Physical Chemistry · doi:10.1021/j100188a023 · Cited by 17
Research works printed but not linked: 29
- Holmer, A. F. Survey: Medicines In Development for HIV/AIDS (Pharmaceutical Research and Manufacturers Association, Washington DC, 2004).
- Ahern, T. J. & Manning, M. C. (eds) Stability of Protein Pharmaceuticals — Part A: Chemical and Physical Pathways of Protein Degradation Pharmaceutical Biotechnology Series Vol. 2 (Plenum, New York, 1992).
- Hussain, A., Arnold, J. J., Khan, M. A. & Ashan, F. Absorption enhancers in pulmonary protein delivery. J. Control. Release 94, 15–24 (2004). · doi:10.1016/j.jconrel.2003.10.001
- Crommelin, D. J. et al. Nanotechnological approaches for the delivery of macromolecules. J. Control. Release 87, 81–88 (2003). · doi:10.1016/s0168-3659(03)00014-2
- Metselaar, J. M., Mastrobattista, E. & Storm, G. Liposomes for intravenous drug targeting: design and applications. Mini Rev. Med. Chem. 2, 319–329 (2002). · doi:10.2174/1389557023405873
- Carpenter, J. F., Kendrick, B. S., Chang, B. S., Manning, M. C. & Randolph, T. W. in Methods in Enzymology (ed. Wetzel, R.) 236–255 (Academic, San Diego, 1999).
- Gidalevitz, D., Zhengoing, H. & Rice, S. A. Protein folding at the air–water interface studied with X-ray reflectivity. Proc. Natl Acad. Sci. USA 96, 2608–2611 (1999). · doi:10.1073/pnas.96.6.2608
- Krishnan, S. et al. Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition. Biochemistry 41, 6422–6431 (2002). · doi:10.1021/bi012006m
- Istrail, S., Schwartz, R. & King, J. Lattice simulations of aggregation funnels for protein folding. J. Comput. Biol. 6, 143–162 (1999). · doi:10.1089/cmb.1999.6.143
- Ferrone, F. Analysis of protein aggregation kinetics. Meth. Enzymol. 309, 256–274 (1999). · DOI · Paper page
- Wadai, H. et al. Stereospecific amyloid-like fibril formation by a peptide fragment of β2-microglobulin. Biochemistry 44, 157–164 (2005). · doi:10.1021/bi0485880
- Partridge, J., Moore, B. D. & Halling, P. J. α-chymotrypsin stability in aqueous-acetonitrile mixtures: is the native enzyme thermodynamically or kinetically stable under low water conditions? J. Mol. Catal., B Enzym. 6, 11–20 (1999). · doi:10.1016/s1381-1177(98)00105-2
- Kerwin, B. A., Heller, M. C., Levin, S. H. & Randolph, T. W. Effects of Tween 80 and sucrose on acute short-term stability and long-term storage at −20° C of a recombinant hemoglobin. J. Pharm. Sci. 87, 1062–1068 (1998). · doi:10.1021/js980140v
- Arakawa, T. & Kita, Y. Protection of bovine serum albumin from aggregation by Tween 80. J. Pharm. Sci. 89, 646–651 (2000). · doi:10.1002/(sici)1520-6017(200005)89:5<646::aid-jps10>3.0.co;2-j
- Tsai, A. M., van Zanten, J. H. & Betenbaugh, M. J. II: Electrostatic effect in the aggregation of heat-denatured RNase A and implications for protein additive design. Biotechnol. Bioeng. 59, 281–285 (1998). · doi:10.1002/(sici)1097-0290(19980805)59:3<281::aid-bit3>3.0.co;2-7
- Larsen, K. L. Large cyclodextrins. Biol. J. Armenia 53, 9–26 (2001).
- Banga, A. K. & Mitra, R. Minimization of shaking-induced formation of insoluble aggregates of insulin by cyclodextrins. J. Drug Target. 1, 341–345 (1993). · doi:10.3109/10611869308996093
- Dotsikas, Y. & Loukas, Y. L. Kinetic degradation study of insulin complexed with methyl-β cyclodextrin. Confirmation of complexation with electrospray mass spectrometry and 1H-NMR. J. Pharm. Biomed. Anal. 29, 487–494 (2002). · doi:10.1016/s0731-7085(02)00076-6
- Tokihiro, K., Irie, T., Uekama, K. & Pitha, J. Potential use of maltosyl-β-cyclodextrin for inhibition of insulin self-association in aqueous solution. Pharm. Sci. 1, 49–53 (1995).
- Hagenlocher, M. & Pearlman, R. Use of a substituted cyclodextrin for stabilization of solutions of recombinant human growth hormone. Pharm. Res. 6, S30 (1989).
- Sigurjonsdottir, J. F., Loftsson, T. & Masson, M. Influence of cyclodextrins on the stability of the peptide salmon calcitonin in aqueous solution. Int. J. Pharm. 186, 205–213 (1999). · doi:10.1016/s0378-5173(99)00183-0
- Aachmann, F. L., Otzen, D. E., Larsen, K. L. & Wimmer, R. Structural background of cyclodextrin–protein interactions. Protein Eng. 16, 1–8 (2003). · doi:10.1093/protein/gzg137
- Cooper, A. Effect of cyclodextrins on the thermal stability of globular proteins. J. Am. Chem. Soc. 114, 9208–9209 (1992). · doi:10.1021/ja00049a074
- Karuppiah, N. & Sharma, A. Cyclodextrins as protein folding aids. Biochem. Biophys. Res. Commun. 211, 60–66 (1995). · doi:10.1006/bbrc.1995.1778
- Easton, C. J. & Lincoln, S. F. Modified Cyclodextrins: Scaffolds and Templates for Supramolecular Chemistry (Imperial College Press, London, 1999). · doi:10.1142/p124
- Franks, F. Protein destabilization at low temperatures. Adv. Protein Chem. 46, 105–139 (1995). · doi:10.1016/s0065-3233(08)60333-2
- Costantino, H. R., Langer, R. & Klibanov, A. M. Moisture-induced aggregation of lyophilized insulin. Pharm. Res. 11, 21–29 (1994). · doi:10.1023/a:1018981208076
- Yoshioka, S., Aso, Y., Izutsu, K. & Terao, T. Aggregates formed during storage of β-galactosidase in solution and in the freeze-dried state. Pharm. Res. 10, 687–691 (1993). · doi:10.1023/a:1018951530927
- Klibanov, A. M. & Schefiliti, J. A. On the relationship between conformation and stability in solid pharmaceutical protein formulations. Bioctechnol. Lett. 26, 1103–1106 (2004). · doi:10.1023/b:bile.0000035520.47933.a6
Cited by
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161
Filipe, V., Hawe, A., & Jiskoot, W. (2010) · Pharmaceutical Research · doi:10.1007/s11095-010-0073-2 · Cited by 1,885
Hydrogels in controlled release formulations: Network design and mathematical modeling
Lin, C.-C., & Metters, A. T. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.004 · Cited by 1,768
Solid lipid nanoparticles as a drug delivery system for peptides and proteins☆
ALMEIDA, A., & SOUTO, E. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.04.007 · Cited by 814
Nanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Soni, K. S., Desale, S. S., & Bronich, T. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 683
Metadata
- Authors
- Frokjaer, S., & Otzen, D. E.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2005-04
- Volume
- 4
- Issue
- 4
- Pages
- 298-306
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1970898345
- Cited by
- 1,096
- References
- 112
- FWCI
- 1.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.